de Vries M, Mohamed AS, Prescott RA, Valero-Jimenez AM, et al. A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL(pro) inhibitor
PF-00835231 as a potential new treatment for COVID-19. J Virol 2021 Feb 23. pii: JVI.01819-20. doi: 10.1128/JVI.01819.
PMID: 33622961